CKD-506

DRUG2 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

Drug Drug InteractionRheumatoid Arthritis

Phase 1

CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects

CompletedNCT05238948

Chong Kun Dang PharmaceuticalDrug Drug Interaction

Start: 2022-02-28End: 2022-04-29Updated: 2022-08-25

Phase 2

A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate

CompletedNCT04204603

Chong Kun Dang PharmaceuticalRheumatoid Arthritis

Start: 2018-11-30End: 2019-10-29Updated: 2019-12-30